Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sinco Pharmaceuticals Holdings Ltd. ( (HK:6833) ) has issued an update.
Sinco Pharmaceuticals Holdings Limited, a Hong Kong-listed pharmaceutical company trading under stock code 06833, operates within the healthcare sector and is subject to oversight and disclosure requirements of the Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited.
The company announced an updated final ordinary cash dividend for the financial year ended 31 December 2025, declaring a payout of HKD 0.00167 per share in Hong Kong dollars, subject to shareholder approval on 15 May 2026. The timetable sets the ex-dividend date on 19 May 2026, a record date of 26 May 2026, and a payment date of 4 June 2026, providing shareholders with visibility on income and reinforcing the company’s practice of returning cash to investors without any applicable withholding tax on the distribution.
The most recent analyst rating on (HK:6833) stock is a Sell with a HK$0.16 price target. To see the full list of analyst forecasts on Sinco Pharmaceuticals Holdings Ltd. stock, see the HK:6833 Stock Forecast page.
More about Sinco Pharmaceuticals Holdings Ltd.
Sinco Pharmaceuticals Holdings Limited is a Hong Kong-listed company in the pharmaceuticals sector. The firm’s equity is traded under stock code 06833 on the Hong Kong Stock Exchange, indicating its focus on healthcare-related products and services within the regional capital markets.
Average Trading Volume: 336,088
Technical Sentiment Signal: Sell
Current Market Cap: HK$353.7M
Find detailed analytics on 6833 stock on TipRanks’ Stock Analysis page.